Cyrulnik Reuvan is categorized under Ultrasonic Scanning Devices, Medical in Brooklyn, NY and active since 2002.
Cyrulnik Reuvan was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Ultrasonic Scanning Devices, Medical business, which does work in the B2B market, and is classified as a Ultrasonic Scanning Devices, Medical, under code number 334510 by the NAICS.
If you are seeking more information, feel free to contact Reuvan Cyrulnik at the company’s single location by writing to 701 Empire Boulevard Apartment 1c, Brooklyn, New York NY 11213 or by phoning (718) 493-4923. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cyrulnik Reuvan |
| Contact Person: | Reuvan Cyrulnik |
| Address: | 701 Empire Boulevard Apartment 1c, Brooklyn, New York 11213 |
| Phone Number: | (718) 493-4923 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Ultrasonic Scanning Devices, Medical |
| SIC Code: | 3845 |
| NAICS Code: | 334510 |
| Share This Business: |
Cyrulnik Reuvan was started in 2002 to provide professional Ultrasonic Scanning Devices, Medical under the SIC code 3845 and NAICS code 334510. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Reuvan Cyrulnik for inquiries that concern Cyrulnik Reuvan by calling the company number (718) 493-4923, as your correspondence is most welcome. Additionally, the physical location of the single location of Cyrulnik Reuvan can be found at the coordinates 40.663991,-73.938812 as well as the street address 701 Empire Boulevard Apartment 1c in Brooklyn, New York 11213.
For its online presence, you may visit Cyrulnik Reuvan’s website at and engage with its social media outlets through on Twitter and on Facebook.